Can I get a blood test at home?

Yes. With Superpower, our team member can organize a blood draw in your home for these biomarkers.

How often should I test?

Use it to establish a baseline and repeat when your risk or health status changes. After an acute event, major surgery, new medicines, pregnancy, or if a prior result was abnormal, rechecking can show whether the thrombo-inflammatory signal is resolving or persisting. In stable situations, infrequent testing is enough; trends over time are more meaningful than frequent single snapshots.

Are there any preparations needed before the blood test for homocysteine, CRP, platelets, NLR?

For homocysteine, a morning draw after an 8–12 hour fast improves consistency. CRP, platelets, and NLR do not require fasting. Come well hydrated and avoid strenuous exercise for 24 hours to reduce transient spikes in inflammatory markers. If you have a current fever or acute infection, results (especially CRP and NLR) will reflect that state.

Thrombophilia: Biomarkers and the Pro-Clotting Balance

Creator: Superpower
Published: 2025-11-06

Understand what your iron blood health results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

Thrombophilia and the pro-clotting side of blood chemistry

Thrombophilia biomarkers are measurable signals that reveal an inherited or acquired tilt toward forming blood clots. They read the balance in your clotting system—the machinery that seals injuries (coagulation) and the built-in brakes that keep blood flowing (anticoagulants). Core markers include the amount or activity of the natural brakes antithrombin, protein C, and protein S (SERPINC1, PROC, PROS1); DNA variants that make clotting harder to turn off, such as Factor V Leiden (F5 R506Q) and the prothrombin G20210A change (F2); and autoimmune flags that trigger clotting on healthy surfaces, the antiphospholipid antibodies (anticardiolipin, anti–β2 glycoprotein I, lupus anticoagulant). Together they show whether your blood’s “stop” signals are weak, its “go” signals are too strong, or the system is being misdirected. Testing turns this biology into practical decisions: explaining unexpected clots, estimating recurrence risk, tailoring the intensity and duration of anticoagulation, and planning protection around life events that raise clot risk (surgery, immobilization, pregnancy, or estrogen use). It can also guide when family members might benefit from evaluation.

Why these markers map your clotting set-point

Thrombophilia blood testing looks at how readily your blood forms clots by integrating signals from coagulation proteins, platelets, vessel wall inflammation, and immune stress. These biomarkers matter because clots form at the intersection of metabolism, inflammation, and hemostasis, affecting lungs (pulmonary embolism), brain (stroke), heart, and pregnancy. Homocysteine is typically about 5–15; optimal tends toward the lower end because higher levels stiffen endothelium and make platelets stickier. CRP is healthiest very low; rising values signal inflammatory drive that amplifies clotting. Platelets are generally 150–400, with risk increasing when counts climb and platelets are activated. The neutrophil‑to‑lymphocyte ratio (NLR) is usually around 1–3; lower‑to‑mid values reflect a calmer immune tone, while higher ratios track systemic stress and prothrombotic inflammation. When these markers run low, they tell a different physiologic story. Low homocysteine generally reflects adequate methylation capacity and does not promote thrombosis. Very low CRP indicates quiet vascular inflammation. Low‑normal NLR suggests minimal stress; if extremely low due to lymphocyte predominance, it can accompany certain viral illnesses rather than clotting. Low platelets reduce clotting capacity and may cause easy bruising, nosebleeds, or heavy periods; in pregnancy, platelets can drift lower yet remain normal, while pregnancy overall increases clot tendency through other pathways. Children normally have slightly lower NLRs; women on estrogen have higher clot risk despite normal counts. Big picture, these tests sit alongside specific thrombophilia assays (e.g., protein C/S, antithrombin, antiphospholipid antibodies, factor mutations) to map your coagulation set‑point. They connect vascular health, metabolism, and immune activity to future risk of deep vein thrombosis, pulmonary embolism, stroke, cardiovascular events, and adverse pregnancy outcomes.

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

Test 150+ biomarkers

Two blood draws. A full picture of your health, explained in plain language.

Book your test

What this panel adds to a thrombophilia workup

Thrombophilia blood testing provides insight into your body’s tendency to form blood clots, a process that can impact cardiovascular health, energy delivery, brain function, and even reproductive outcomes. At Superpower, we assess four key biomarkers—Homocysteine, C-reactive protein (CRP), platelets, and the neutrophil-to-lymphocyte ratio (NLR)—to build a systems-level picture of your clotting risk and overall vascular stability. Homocysteine is an amino acid that, when elevated, can damage blood vessel linings and promote clot formation. CRP is a marker of inflammation; higher levels signal increased inflammatory activity, which can make blood more prone to clotting. Platelets are cell fragments essential for normal clotting, but too many or too few can disrupt the balance between bleeding and clotting. The NLR reflects the balance between two types of white blood cells and serves as a general marker of immune system activation and inflammation, both of which can influence clotting risk. Together, these biomarkers reveal how well your body maintains the delicate balance between preventing excessive bleeding and avoiding dangerous clots. Stable, healthy levels suggest your vascular and immune systems are working in harmony, supporting efficient circulation and organ function. Imbalances may indicate a higher risk for clot-related complications, affecting everything from heart and brain health to fertility. Interpretation of these results depends on factors like age, pregnancy, acute illness, medications (such as anticoagulants or hormone therapy), and laboratory methods. These variables can shift biomarker levels, so results are always considered in context.

Frequently Asked Questions

Thrombophilia means a higher-than-normal tendency to form blood clots. Blood testing looks at the forces that push your blood toward clotting or away from it—platelet mass and activation, inflammatory tone, and endothelial stress. Superpower measures four key signals: Homocysteine (methylation/endothelial injury), CRP (systemic inflammation), platelets (thrombocyte count), and NLR, the neutrophil-to-lymphocyte ratio (immune stress balance). Together, these markers characterize your thrombo-inflammatory state. They don’t diagnose a clot by themselves, but they help explain your physiologic risk and whether your system is primed to clot.

To understand your personal clotting risk and the inflammatory forces that drive it. This is useful if you’ve had a clot, miscarriage, early cardiovascular events, a strong family history, or new risk exposures such as surgery, immobility, cancer, or hormones. Results can clarify whether your biology currently leans pro-thrombotic (inflammation, high platelets, high homocysteine, high NLR) or not. It’s a risk profile, not a diagnosis, but it helps make sense of events and informs future medical decisions.

Any acute stressor. Infection, surgery, trauma, fever, and hard exercise raise CRP and NLR. Dehydration concentrates platelets; recovery and fluids lower them. Smoking, pregnancy, estrogen therapy, and inflammation shift platelet kinetics. Homocysteine rises with low B-vitamin status and with kidney or thyroid dysfunction. Steroids increase NLR; chemotherapy or heparin can lower platelets; growth factors increase them. Recent travel/immobility, cancer, and chronic inflammatory diseases push the system pro-thrombotic. Time of day and posture cause small shifts.

Yes. Systemic inflammation and physiologic stress strongly influence CRP and NLR. Smoking and estrogen exposure affect platelet behavior and clotting tendency. Diet quality and B‑vitamin status influence homocysteine by altering one‑carbon metabolism. Sleep, physical activity, and body weight alter inflammatory tone, and hydration can mildly shift apparent platelet counts. These are biology-driven responses, not just lab noise.

Higher homocysteine signals impaired methylation and endothelial stress (pro‑thrombotic milieu). Elevated CRP and NLR indicate active inflammation and immune stress that amplify clotting pathways. High platelets (thrombocytosis) can raise clot risk; very low platelets (thrombocytopenia) raise bleeding risk. Patterns matter: multiple elevated markers suggest a heightened thrombo‑inflammatory state; normal values suggest low systemic clotting drive. Single results are a snapshot; repeat values and clinical context (age, medications, pregnancy, illness) determine significance. These tests stratify risk—they do not confirm or exclude an active clot.